Get started
Author

Patricia Jáuregui

Observed names: P. J. Jauregui, P. Jauregui, Patricia Jauregui, Patricia Jaúregui
Observed institutions: University of the Basque Country, Universidad Pública de Navarra (UPNA), Complejo Hospitalario de Navarra, Polymat, Biogipuzkoa Health Research Institute, Navarre Institute of Health Research, Pitié-Salpêtrière Hospital, Hospital Universitario Fundación Jiménez Díaz, Clinica Universidad de Navarra, Donostiako Unibertsitate Ospitalea, Fundació Clínic per a la Recerca Biomèdica, Centro de Investigación Biomédica en Red de Cáncer, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Centro de Investigación Médica Aplicada, Universitat de Barcelona, Universidad de Navarra
ORCID: 0009-0003-5307-5786
Observed ORCID: 0009-0003-5307-5786
OpenAlex ID: A5067244660
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
2014 · Lorea Manterola, Elizabeth Guruceaga, et al. · Neuro-Oncology · 357
PDF
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
2022 · Paula Rodriguez-Marquez, Maria E. Calleja-Cervantes, et al. · Science Advances · 115
PDF
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
2019 · Patricia Fernández-Nogueira, Mario Mancino, et al. · Clinical Cancer Research · 106
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation
2021 · Itziar Otano, Arantza Azpilikueta, et al. · Nature Communications · 94
PDF
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer
2018 · Patricia Fernández-Nogueira, Aleix Noguera-Castells, et al. · Cancer Letters · 65
PDF
The Oncolytic Adenovirus Δ24-RGD in Combination With Cisplatin Exerts a Potent Anti-Osteosarcoma Activity
2014 · Naiara Martinez-Velez, Enric Xipell, et al. · Journal of Bone and Mineral Research · 33
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
2023 · Cristina Calviño, Candela Ceballos, et al. · Frontiers in Immunology · 28
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer
2020 · Anna López‐Plana, Patricia Fernández‐Nogueira, et al. · International Journal of Cancer · 24
PDF
Effect of a Diet Supplemented with Sphingomyelin and Probiotics on Colon Cancer Development in Mice
2022 · Florencio Marzo, Patricia Jauregui, et al. · Probiotics and Antimicrobial Proteins · 17
PDF
C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells
2021 · Sara Manzano, Alvaro Gutierrez-Uzquiza, et al. · Cell Death and Disease · 17
PDF
CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome
2021 · Paula Rodriguez-Marquez, Maria Erendira Calleja-Cervantes, et al. · Blood · 16
Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML
2025 · Franco Bernasconi-Bisio, Eva Molina, et al. · Molecular Therapy Oncology · 9
Optimization of a Universal Allogeneic CAR-T Cells Combining CRISPR and Transposon-Based Technologies for Treatment of Acute Myeloid Leukemia
2023 · Candela Ceballos Bolaños, Cristina Calviño, et al. · Blood · 3
Abstracts
2013 · L. Bie, Y. Ju, et al. · Neuro-Oncology · 3
PDF
Effects of diets supplemented with sphingomyelin and Lactobacillus casei and Bifidobacterium bifidum on colon cancer development
2008 · Marzo Florencio, Urdaneta Elena, et al. · The FASEB Journal · 2
BCMA CAR-T Cell Phenotype and Functionality Is Affected By Disease Stage of Multiple Myeloma Patients
2022 · Angel Martin-Mallo, Maria Erendira Calleja-Cervantes, et al. · Blood · 1
Lab-omics and Prognostic Markers
2012 · R. L. Jensen, S. Abraham, et al. · Neuro-Oncology · 1
PDF
Lab-pediatrics Laboratory Research
2012 · D. Carvalho, L. Bjerke, et al. · Neuro-Oncology · 1
PDF
Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreatic cancer
2026 · Maria Bunuales, Susana Inoges, et al. · Gene Therapy
Single-cell multiomic dissection of human hematopoietic stem cells reveals novel transcriptional fingerprints and regulatory programs in bone marrow and mobilized peripheral blood
2025 · Daniel Mouzo, Asier Ortega-Legarreta, et al. · Blood
PDF
Identification and Evaluation of Novel Sdab-Based CAR-T Cells Against BCMA with Improved Therapeutic Efficacy for Multiple Myeloma
2024 · Vianca Ibarra-Garcia, Eva Molina, et al. · Blood
P-073 Identification and Validation of Factors Promoting Resistance to CAR-T Therapy in Multiple Myeloma by Genome-Wide CRISPR Screenings
2024 · Paula Rodriguez-Marquez, Yimei Que, et al. · Clinical Lymphoma Myeloma & Leukemia
271 Development and characterisation of humanised scFv CAR-T therapies targeting BCMA against multiple myeloma
2023 · Jorge Illarramendi, Rebeca Martinez-Turrillas, et al. · Journal for ImmunoTherapy of Cancer
PDF
Supplementary Figure S5 from Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
2023 · Patricia Fernández-Nogueira, Mario Mancino, et al.
PDF
Supplementary Figure S4 from Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
2023 · Patricia Fernández-Nogueira, Mario Mancino, et al.
Works count: 44
Citation count: 884
H-index: 11
I10-index: 11
Year
Topic
Type